LGALS9 and familial pancreatic carcinoma: Using a mouse preclinical pancreatic cancer model, Zhou and colleagues have shown that it is possible to inhibit galectin-9 expression in the host following the intravenous injection of galectin-9-specific siRNA-loaded exosomes (66).